Skip to main content
Movement Disorders
resource center
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
AbbVie Partner Spotlight
Commentary
Disease State Directory
FDA Alerts
News
Pearls
Podcasts
Polls
Q&As
Quizzes
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Advertising With Consultant360
Search
Login
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
AbbVie Partner Spotlight
Commentary
Disease State Directory
FDA Alerts
News
Pearls
Podcasts
Polls
Q&As
Quizzes
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Advertising With Consultant360
Movement Disorders
Resource Center
News
News
Resources
FDA Alerts
Pearls of Wisdom
From the Journal
Insights
Commentary
Podcasts
Q&As
Videos
Interactive
Polls
Quizzes
Slideshows
Events & Education
FDA Alerts
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis
FDA Approves New Medication for Treatment of ALS
10/07/2022
10/07/2022
Movement Disorders
Movement Disorders
FDA Approves New Add-on Therapy for Parkinson Disease
08/28/2019
After 4 clinical trials showed the treatment decreased daily “off” time, the FDA approved this new add-on therapy for adults with Parkinson disease.
08/28/2019
